← Leaderboards

John C. Cambier

National Jewish Health

Google Scholar ↗PubMed ↗ORCID ↗

$24,404,039

Attributed

$26,823,402

Total exposure

29

Grants

19

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.9M · FY2005–24

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$26,823,402 · 29

By mechanism

R01$15,047,953 · 9

T32$4,135,816 · 1

P01$2,503,152 · 4

R21$1,864,322 · 5

DP3$1,688,865 · 1

R43$599,638 · 1

Top collaborators

Most similar at National Jewish Health

Same institution · by research overlap

Gary L. Johnson$39,128,449
Hong W Chu$18,238,701
G Scott Worthen$17,039,709
Peter M Henson$23,575,855
Dennis R Voelker$17,845,148

Others in their field

Top investigators on “Molecular”

David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
Richard Webby · St. Jude Children'S Research Hospital$254,843,170
Larry Arthur$238,531,074
Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914

Research focus

MolecularCellsB-LymphocytesAnergyPhosphorylationImmune ToleranceMediatingAntigensSignal TransductionBaseResponseAutoimmunityAntigen ReceptorsAutoantibodiesBiological Signal TransductionSignal PathwayPathway InteractionsPreventAutoantigensAutoimmune DiseasesGenetically Modified AnimalsResearch StudyLaboratory MouseCell Surface

Grant awards (100)

Silencing autoantibody secretion for SLE therapy$299,773

R43 · FY2024 · AI

Molecular Mechanisms of Immune Tolerance$394,085

T32 · FY2023 · AI

Silencing autoantibody secretion for SLE therapy$299,865

R43 · FY2023 · AI

Molecular Mechanisms of Immune Tolerance$388,265

T32 · FY2022 · AI

Molecular Mechanisms of Immune Tolerance$364,139

T32 · FY2021 · AI

Autoimmunity risk alleles compromising B cell anergy$457,386

R01 · FY2020 · AI · contact PI

Molecular Mechanisms of Immune Tolerance$358,131

T32 · FY2020 · AI

Autoimmunity risk alleles compromising B cell anergy$457,386

R01 · FY2019 · AI · contact PI

Molecular Mechanisms of Immune Tolerance$338,755

T32 · FY2019 · AI

Autoimmunity risk alleles compromising B cell anergy$457,386

R01 · FY2018 · AI · contact PI

Molecular Mechanisms of Immune Tolerance$257,316

T32 · FY2018 · AI

Autoimmunity risk alleles compromising B cell anergy$135,887

R01 · FY2018 · AI · contact PI

Autoimmunity risk alleles compromising B cell anergy$457,386

R01 · FY2017 · AI · contact PI

Molecular Mechanisms of Immune Tolerance$249,653

T32 · FY2017 · AI

Perturbation of B cell anergy in T1D$194,375

R21 · FY2017 · AI · contact PI

Autoimmunity risk alleles compromising B cell anergy$112,562

R01 · FY2017 · AI · contact PI

Insulin Specific T and B cells in Type 1 Diabetes$1,688,865

DP3 · FY2016 · DK

Autoimmunity risk alleles compromising B cell anergy$455,054

R01 · FY2016 · AI · contact PI

B Cells and Type 1 Diabetes$325,125

R01 · FY2016 · DK · contact PI

Molecular Mechanisms of Immune Tolerance$238,948

T32 · FY2016 · AI · contact PI

Perturbation of B cell anergy in T1D$233,250

R21 · FY2016 · AI · contact PI

B Cells and Type 1 Diabetes$325,125

R01 · FY2015 · DK · contact PI

Molecular Mechanisms of Immune Tolerance$228,938

T32 · FY2015 · AI · contact PI

Infectious Agents and B Cell Anergy$378,675

R01 · FY2014 · AI · contact PI

B Cells and Type 1 Diabetes$325,125

R01 · FY2014 · DK · contact PI

Molecular Mechanisms of Immune Tolerance$239,008

T32 · FY2014 · AI · contact PI

Infectious Agents and B Cell Anergy$355,955

R01 · FY2013 · AI · contact PI

B Cells and Type 1 Diabetes$313,746

R01 · FY2013 · DK · contact PI

Molecular Mechanisms of Immune Tolerance$225,331

T32 · FY2013 · AI · contact PI

Mouse modeling of a human STING gene variant for infectious disease$217,904

R21 · FY2013 · AI · contact PI

Infectious Agents and B Cell Anergy$378,675

R01 · FY2012 · AI · contact PI

B Cells and Type 1 Diabetes$325,125

R01 · FY2012 · DK · contact PI

Molecular Mechanisms of Immune Tolerance$215,689

T32 · FY2012 · AI · contact PI

Mouse modeling of a human STING gene variant for infectious disease$192,552

R21 · FY2012 · AI · contact PI

Infectious Agents and B Cell Anergy$378,675

R01 · FY2011 · AI · contact PI

Maintenance of B Cell Anergy$318,545

P01 · FY2011 · AI · contact PI

Molecular Mechanisms of Immune Tolerance$214,012

T32 · FY2011 · AI · contact PI

Flow Cytometry$117,274

P01 · FY2011 · AI · contact PI

iCyt Reflection High Speed Cell Sorter$499,998

S10 · FY2010 · RR · contact PI

B Cells and Autoimmunity$390,046

R01 · FY2010 · AG · contact PI

Infectious Agents and B Cell Anergy$383,230

R01 · FY2010 · AI · contact PI

Maintenance of B Cell Anergy$326,275

P01 · FY2010 · AI · contact PI

Molecular Mechanisms of Immune Tolerance$216,510

T32 · FY2010 · AI · contact PI

B Cell Development in Aging$189,338

R21 · FY2010 · AI · contact PI

Flow Cytometry$120,917

P01 · FY2010 · AI · contact PI

B Cells and Autoimmunity$382,055

R01 · FY2009 · AG · contact PI

NKIP signaling and functions$362,764

R01 · FY2009 · AI · contact PI

NKIP signaling and functions$332,895

R01 · FY2009 · AI · contact PI

Maintenance of B Cell Anergy$316,824

P01 · FY2009 · AI · contact PI

Molecular Mechanisms of Immune Tolerance$207,036

T32 · FY2009 · AI · contact PI

B Cell Development in Aging$191,875

R21 · FY2009 · AI · contact PI

Flow Cytometry$117,445

P01 · FY2009 · AI · contact PI

NKIP signaling and functions$21,116

R01 · FY2009 · AI · contact PI

NKIP signaling and functions$362,764

R01 · FY2008 · AI · contact PI

Maintenance of B Cell Anergy$310,096

P01 · FY2008 · AI · contact PI

Flow Cytometry$119,303

P01 · FY2008 · AI · contact PI

IMMUNOLGICAL RESPONSES TO IMMUNOTHERAPY IN CAT ALLERGENS$593

M01 · FY2008 · RR · contact PI

Inhibitory receptors and their mode of action$385,000

R56 · FY2007 · AI · contact PI

NKIP signaling and functions$369,790

R01 · FY2007 · AI · contact PI

Molecular Biology of B Cell Tolerance and Activation$328,545

R01 · FY2007 · AI · contact PI

Maintenance of B Cell Anergy$306,811

P01 · FY2007 · AI · contact PI

Characterization of anergic human B cells$186,918

R21 · FY2007 · AI · contact PI

Flow Cytometry$115,306

P01 · FY2007 · AI · contact PI

Signal Transduction in B cell Activation$37,800

R01 · FY2007 · AG · contact PI

IMMUNOLOGICAL RESPONSES TO IMMUNOTHERAPY IN CAT ALLERGENS$7,069

M01 · FY2007 · RR · contact PI

Molecular Biology of B Cell Tolerance and Activation$338,358

R01 · FY2006 · AI · contact PI

Characterization of anergic human B cells$192,500

R21 · FY2006 · AI · contact PI

Aging Research in Immunology: Satellite to 2006 European Congress of Immunology$43,000

R13 · FY2006 · AG · contact PI

IMMUNOLGICAL RESPONSES TO IMMUNOTHERAPY IN CAT ALLERGENS$12,996

M01 · FY2006 · RR · contact PI

Signal Transduction in B cell Activation$385,000

R01 · FY2005 · AG

Molecular Biology of B Cell Tolerance and Activation$346,500

R01 · FY2005 · AI

FASEB Conference-Immunoreceptors$22,500

R13 · FY2005 · AI

Signal Transduction in B cell Activation$384,791

R01 · FY2004 · AG

Molecular Biology of B Cell Tolerance and Activation$345,750

R01 · FY2004 · AI

HIV GP120 Desensitization of T Cell Receptor Function$300,580

R01 · FY2004 · AI

INHIBITORY RECEPTORS AND THEIR MODE OF ACTION$232,892

R01 · FY2004 · DK

Signal Transduction in B cell Activation$382,084

R01 · FY2003 · AG

Molecular Biology of B Cell Tolerance and Activation$342,750

R01 · FY2003 · AI

HIV GP120 Desensitization of T Cell Receptor Function$298,108

R01 · FY2003 · AI

INHIBITORY RECEPTORS AND THEIR MODE OF ACTION$224,115

R01 · FY2003 · DK

Signal Transduction in B cell Activation$380,250

R01 · FY2002 · AG

INHIBITORY RECEPTORS AND THEIR MODE OF ACTION$220,406

R01 · FY2002 · DK

HIV GP120 Desensitization of T Cell Receptor Function$104,288

R01 · FY2002 · AI

Conference Proposal: IMMUNORECEPTORS$12,500

R13 · FY2002 · CA

CORE--FLOW CYTOMETRY FACILITY$0

P01 · FY2002 · AI

MU-DELTA ARS/A1 MOUSE MODEL FOR B CELL ANERGY$0

P01 · FY2002 · AI

Signal Transduction in B cell Activation$380,250

R01 · FY2001 · AG

MOLECULAR BIOLOGY OF B CELL TOLERANCE AND ACTIVATION$294,573

R01 · FY2001 · AI

IGC REGULATION OF IGE-MEDIATED BASOPHIL DEGRANULATION$245,451

R01 · FY2001 · AI

INHIBITORY RECEPTORS AND THEIR MODE OF ACTION$213,988

R01 · FY2001 · DK

HIV GP120 Desensitization of TCell Receptor Function$149,635

R21 · FY2001 · AI

HIV GP120 Desensitization of TCell Receptor Function$115,975

R21 · FY2001 · AI

CORE--FLOW CYTOMETRY FACILITY$0

P01 · FY2001 · AI

MU-DELTA ARS/A1 MOUSE MODEL FOR B CELL ANERGY$0

P01 · FY2001 · AI

MOLECULAR BIOLOGY OF B CELL TOLERANCE AND ACTIVATION$285,993

R01 · FY2000 · AI

SIGNAL TRANSDUCTION IN B CELL ACTIVATION$282,248

R01 · FY2000 · AG

IGC REGULATION OF IGE-MEDIATED BASOPHIL DEGRANULATION$238,304

R01 · FY2000 · AI

INHIBITORY RECEPTORS AND THEIR MODE OF ACTION$210,996

R01 · FY2000 · DK

ROLE OF ANTIGEN STRUCTURE IN DETERMINING CONSEQUENCES OF MIG-MEDIATED SIGNALING$167,178

P01 · FY2000 · AI

CORE--FLOW CYTOMETRY FACILITY$167,178

P01 · FY2000 · AI